NFE2L2 and hepatocellular carcinoma: CTNNB1 mutations in HCC significantly co-exist with other genetic aberrant changes, such as overexpression of MET and MYC and mutations in TERT promoter, as well as in NFE2L2/KEAP1, APOB, and ARID2 genes.